Legacy Private Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,800
Closed -$265K 220
2019
Q4
$265K Hold
2,800
0.03% 213
2019
Q3
$243K Hold
2,800
0.03% 217
2019
Q2
$256K Buy
+2,800
New +$237K 0.03% 214
2015
Q4
Sell
-2,544
Closed -$210K 254
2015
Q3
$210K Hold
2,544
0.03% 226
2015
Q2
$224K Sell
2,544
-123
-5% -$11.3K 0.03% 232
2015
Q1
$236K Sell
2,667
-9,975
-79% -$885K 0.03% 227
2014
Q4
$1.05M Buy
12,642
+2,232
+21% +$185K 0.15% 143
2014
Q3
$878K Sell
10,410
-56
-0.5% -$4.53K 0.13% 153
2014
Q2
$849K Buy
+10,466
New +$823K 0.13% 150

Other funds holding NVS

Legacy Private Trust's NVS Position: Q1 2020 in Review

Legacy Private Trust sold out of Novartis (NVS) in Q1 2020, closing a stake of 2,800 shares — an estimated $265K sold.

Legacy Private Trust first reported a position in NVS in Q2 2014 and held it in 9 quarters. The position peaked at $1.05M in Q4 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • Legacy Private Trust reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
  • Legacy Private Trust sold 2,800 Novartis shares in Q1 2020, an estimated $265K.
  • Legacy Private Trust first reported a position in Novartis in Q2 2014 and held it in 9 quarters.
  • Legacy Private Trust's Novartis position peaked at $1.05M in Q4 2014.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Legacy Private Trust's 13F filing for Q1 2020, filed 23 Apr 2020.